Intech Investment Management LLC lifted its position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 21.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,578 shares of the real estate investment trust's stock after purchasing an additional 5,117 shares during the quarter. Intech Investment Management LLC owned 0.06% of National Health Investors worth $2,111,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC increased its stake in shares of National Health Investors by 49.8% in the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust's stock worth $33,000 after acquiring an additional 147 shares during the last quarter. M&T Bank Corp lifted its stake in National Health Investors by 4.4% during the first quarter. M&T Bank Corp now owns 3,969 shares of the real estate investment trust's stock worth $293,000 after purchasing an additional 168 shares during the last quarter. Focus Partners Wealth lifted its stake in National Health Investors by 4.0% in the fourth quarter. Focus Partners Wealth now owns 4,867 shares of the real estate investment trust's stock valued at $337,000 after buying an additional 188 shares during the last quarter. Vident Advisory LLC lifted its stake in National Health Investors by 1.6% in the first quarter. Vident Advisory LLC now owns 12,691 shares of the real estate investment trust's stock valued at $938,000 after buying an additional 201 shares during the last quarter. Finally, Xponance Inc. raised its stake in shares of National Health Investors by 11.2% during the first quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust's stock worth $246,000 after purchasing an additional 337 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.
Analysts Set New Price Targets
Several research firms have weighed in on NHI. Wedbush raised National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. KeyCorp upgraded National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research report on Thursday, July 10th. Truist Financial upped their price objective on National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. Finally, Wells Fargo & Company boosted their target price on National Health Investors from $76.00 to $80.00 and gave the stock an "equal weight" rating in a research report on Wednesday, August 27th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $84.20.
Check Out Our Latest Analysis on National Health Investors
National Health Investors Stock Down 0.9%
NYSE NHI traded down $0.68 during trading hours on Friday, hitting $78.55. The company's stock had a trading volume of 438,792 shares, compared to its average volume of 189,643. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $3.73 billion, a PE ratio of 25.10, a price-to-earnings-growth ratio of 3.40 and a beta of 0.76. National Health Investors, Inc. has a 52 week low of $65.13 and a 52 week high of $85.69. The company's 50-day simple moving average is $74.94 and its two-hundred day simple moving average is $73.72.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The firm had revenue of $70.27 million during the quarter, compared to analyst estimates of $86.46 million. During the same quarter last year, the business posted $1.18 EPS. The company's revenue for the quarter was up 6.7% on a year-over-year basis. Research analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.7%. This is an increase from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's payout ratio is presently 115.02%.
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.